Study of LM-302 in Patients With Advance Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jianping Xiong
The First Affiliated Hospital of Nanchang University
Principal Investigator - Jin Li
Shanghai East Hospital
Principal Investigator - Wei Shen
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Principal Investigator - Wenhui Lou
Shanghai Zhongshan Hospital
Principal Investigator - Yanqiao Zhang
The Second Affiliated Hospital of Harbin Medical University
Principal Investigator - Yuping Sun
Shandong Province Cancer Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shanghai East Hospital
Shanghai, Shanghai Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Nov 2021
- Primary completion
- 10 Jan 2025
- Completion
- 10 Jan 2025
- Last update posted
- 12 Sept 2025
- Registered enrollment
- 153
- Registry id
- NCT05161390
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.